LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Berger, Peter; Lapthorn, Adrian J. (2016)
Publisher: Elsevier
Languages: English
Types: Article
Subjects:
Antigenic domains are defined to contain a limited number of neighboring epitopes recognized by antibodies (Abs) but their molecular relationship remains rather elusive. We thoroughly analyzed the antigenic surface of the important pregnancy and tumor marker human chorionic gonadotropin (hCG), a cystine knot (ck) growth factor, and set antigenic domains and epitopes in molecular relationships to each other. Antigenic domains on hCG, its free hCGα and hCGβ subunits are dependent on appropriate inherent molecular features such as molecular accessibility and protrusion indices that determine bulging structures accessible to Abs. The banana-shaped intact hCG comprises ∼7500 Å2 of antigenic surface with minimally five antigenic domains that encompass a continuum of overlapping non-linear composite epitopes, not taking into account the C-terminal peptide extension of hCGβ (hCGβCTP). Epitopes within an antigenic domain are defined by specific Abs, that bury nearly 1000 Å2 of surface accessible area on the antigen and recognize a few up to 15 amino acid (aa) residues, whereby between 2 and 5 of these provide the essential binding energy. Variability in Ab binding modes to the contact aa residues are responsible for the variation in affinity and intra- and inter-species specificity, e.g. cross-reactions with luteinizing hormone (LH). Each genetically distinct fragment antigen binding (Fab) defines its own epitope. Consequently, recognition of the same epitope by different Abs is only possible in cases of genetically identical sequences of its binding sites. Due to combinatorial V(D)J gene segment variability of heavy and light chains, Abs defining numerous epitopes within an antigenic domain can be generated by different individuals and species. Far more than hundred Abs against the immuno-dominant antigenic domains of either subunit at both ends of the hCG-molecule, the tips of peptide loops one and three (Ł1 + 3) protruding from the central ck, encompassing hCGβŁ1 + 3 (aa 20–25 + 64 + 68–81) and hCGαŁ1 (aa 13–22; Pro16, Phe17, Phe18) plus hCGαŁ3 (Met71, Phe74), respectively, have been identified in the two “ISOBM Tissue Differentiation-7 Workshops on hCG and Related Molecules” and in other studies. These Abs recognize distinct but overlapping epitopes with slightly different specificity profiles and affinities. Heterodimeric-specific epitopes involve neighboring αŁ1 plus βŁ2 (hCGβ44/45 and 47/48). Diagnostically important Abs recognize the middle of the molecule, the ck (aa Arg10, Arg60 and possibly Gln89) and the linear hCGβCTP “tail” (aa 135–145; Asp139, Pro144, Gln145), respectively. Identification of antigenic domains and of specific epitopes is essential for harmonization of Abs in methods that are used for reliable and robust hCG measurements for the management of pregnancy, pregnancy-related disease and tumors.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • [1] J.F. O'Connor, S. Birken, J.W. Lustbader, A. Krichevsky, Y. Chen, R.E. Canfield, Recent advances in the chemistry and immunochemistry of human chorionic gonadotropin: impact on clinical measurements, Endocr Rev, 15 (1994) 650-683.
    • [2] U.H. Stenman, H. Alfthan, K. Hotakainen, Human chorionic gonadotropin in cancer, Clin Biochem, 37 (2004) 549-561.
    • [3] U.H. Stenman, A. Tiitinen, H. Alfthan, L. Valmu, The classification, functions and clinical use of different isoforms of HCG, Hum Reprod Update, 12 (2006) 769-784.
    • [4] P. Berger, C. Sturgeon, Pregnancy testing with hCG--future prospects, Trends in endocrinology and metabolism: TEM, 25 (2014) 637-648.
    • [5] S.F. de Medeiros, R.J. Norman, Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights, Hum Reprod Update, 15 (2009) 69-95.
    • [6] U.H. Stenman, J.M. Bidart, S. Birken, K. Mann, B. Nisula, J. O'Connor, Standardization of protein immunoprocedures. Choriogonadotropin (CG), Scand J Clin Lab Invest Suppl, 216 (1993) 42-78.
    • [7] P. Berger, C. Sturgeon, J.M. Bidart, E. Paus, R. Gerth, M. Niang, A. Bristow, S. Birken, U.H. Stenman, The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives, Tumor Biol, 23 (2002) 1-38.
    • [8] S. Birken, P. Berger, J.M. Bidart, M. Weber, A. Bristow, R. Norman, C. Sturgeon, U.H. Stenman, Preparation and characterization of new WHO reference reagents for human chorionic gonadotropin and metabolites, Clin Chem, 49 (2003) 144-154.
    • [9] A. Bristow, P. Berger, J.M. Bidart, S. Birken, R. Norman, U.H. Stenman, C. Sturgeon, Establishment, value assignment, and characterization of new WHO reference reagents for six molecular forms of human chorionic gonadotropin, Clin Chem, 51 (2005) 177-182.
    • [10] C.M. Sturgeon, P. Berger, J.M. Bidart, S. Birken, C. Burns, R.J. Norman, U.H. Stenman, Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin, Clin Chem, 55 (2009) 1484-1491.
    • [11] A.J. Lapthorn, D.C. Harris, A. Littlejohn, J.W. Lustbader, R.E. Canfield, K.J. Machin, F.J. Morgan, N.W. Isaacs, Crystal structure of human chorionic gonadotropin, Nature, 369 (1994) 455-461.
    • [12] P. Berger, S. Schwarz, G. Spottl, G. Wick, K. Mann, Variants of human chorionic gonadotropin from pregnant women and tumor patients recognized by monoclonal antibodies, J Clin Endocrinol Metab, 77 (1993) 347-351.
    • [13] H. Toll, P. Berger, A. Hofmann, A. Hildebrandt, H. Oberacher, H.P. Lenhof, C.G. Huber, Glycosylation patterns of human chorionic gonadotropin revealed by liquid chromatography-mass spectrometry and bioinformatics, Electrophoresis, 27 (2006) 2734-2746.
    • [14] J.C. Fiddes, H.M. Goodman, The cDNA for the beta-subunit of human chorionic gonadotropin suggests evolution of a gene by readthrough into the 3'-untranslated region, Nature, 286 (1980) 684- 687.
    • [15] S. Dirnhofer, R. Klieber, R. De Leeuw, J.M. Bidart, W.E. Merz, G. Wick, P. Berger, Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin beta: implications for the WHO birth control vaccine, FASEB J, 7 (1993) 1381-1385.
    • [16] M.M. Matzuk, A.J. Hsueh, P. Lapolt, A. Tsafriri, J.L. Keene, I. Boime, The biological role of the carboxyl-terminal extension of human chorionic gonadotropin [corrected] beta-subunit, Endocrinology, 126 (1990) 376-383.
    • [17] F. Fares, A. Havron, E. Fima, Designing a Long Acting Erythropoietin by Fusing Three CarboxylTerminal Peptides of Human Chorionic Gonadotropin beta Subunit to the N-Terminal and C-Terminal Coding Sequence, International journal of cell biology, 2011 (2011) 275063.
    • [18] P.J. Delves, R.K. Iles, I.M. Roitt, T. Lund, Designing a new generation of anti-hCG vaccines for cancer therapy, Mol Cell Endocrinol, 260-262 (2007) 276-281.
    • [19] W.E. Merz, J.M. Krause, J. Roig, V. Singh, P. Berger, Nonassembled Human Chorionic Gonadotropin Subunits and {alpha}{alpha}-Homodimers Use Fast-Track Processing in the Secretory Pathway in Contrast to {alpha}{beta}-Heterodimers, Endocrinology, 148 (2007) 5831-5841.
    • [20] S. Schwarz, P. Berger, G. Wick, Epitope-selective, monoclonal-antibody-based immunoradiometric assays of predictable specificity for differential measurement of choriogonadotropin and its subunits, Clin Chem, 31 (1985) 1322-1328.
    • [21] S. Madersbacher, P. Berger, K. Mann, R. Kuzmists, G. Wick, Diagnostic value of free subunits of serum chorionic gonadotropin in testicular cancer, Lancet, 336 (1990) 630-631.
  • No related research data.
  • No similar publications.
  • BioEntity Site Name
    1hrpProtein Data Bank
    1qfwProtein Data Bank
    1sbsProtein Data Bank

Share - Bookmark

Download from

Cite this article